InMed Pharma’s Major Acquisition Boosts Cannabis‑Based Drug Development
InMed Pharmaceuticals’ July 2026 cannabis‑therapy takeover reshapes its biopharma future, unlocking proprietary platform tech and new growth opportunities.
2 minutes to read
INMED PHARMACEUTICALS INC
InMed Pharmaceuticals Faces Financial Struggles Amid Biotech Sector Volatility
InMed Pharmaceuticals Inc. is facing significant financial challenges and a decline in stock value, raising concerns about its ability to sustain operations and achieve its ambitious goals in the biotech sector.
3 minutes to read
InMed Pharmaceuticals Faces Market Volatility Amidst Push for Cannabis-Based Therapies
InMed Pharmaceuticals continues to navigate the biotechnology market with its innovative cannabis-based therapies, despite experiencing significant stock fluctuations and market volatility.
2 minutes to read